HK1214772A1 - 生產二酮基呱嗪和含有二酮基呱嗪的組合物的方法 - Google Patents

生產二酮基呱嗪和含有二酮基呱嗪的組合物的方法 Download PDF

Info

Publication number
HK1214772A1
HK1214772A1 HK16102846.4A HK16102846A HK1214772A1 HK 1214772 A1 HK1214772 A1 HK 1214772A1 HK 16102846 A HK16102846 A HK 16102846A HK 1214772 A1 HK1214772 A1 HK 1214772A1
Authority
HK
Hong Kong
Prior art keywords
dkp
albumin
diketopiperazines
methods
compositions
Prior art date
Application number
HK16102846.4A
Other languages
English (en)
Chinese (zh)
Inventor
David Bar-Or
Original Assignee
Ampio Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ampio Pharmaceuticals, Inc. filed Critical Ampio Pharmaceuticals, Inc.
Publication of HK1214772A1 publication Critical patent/HK1214772A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biomedical Technology (AREA)
HK16102846.4A 2013-02-01 2014-02-03 生產二酮基呱嗪和含有二酮基呱嗪的組合物的方法 HK1214772A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759922P 2013-02-01 2013-02-01
US61/759,922 2013-02-01
PCT/US2014/014478 WO2014121210A1 (en) 2013-02-01 2014-02-03 Methods for producing diketopiperazines and compositions containing diketopiperazines

Publications (1)

Publication Number Publication Date
HK1214772A1 true HK1214772A1 (zh) 2016-08-05

Family

ID=51263032

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102846.4A HK1214772A1 (zh) 2013-02-01 2014-02-03 生產二酮基呱嗪和含有二酮基呱嗪的組合物的方法

Country Status (15)

Country Link
US (1) US20150366932A1 (cg-RX-API-DMAC7.html)
EP (1) EP2950811A4 (cg-RX-API-DMAC7.html)
JP (1) JP6387019B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150114984A (cg-RX-API-DMAC7.html)
CN (1) CN105188737A (cg-RX-API-DMAC7.html)
AU (1) AU2014212095B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015017958A2 (cg-RX-API-DMAC7.html)
CA (1) CA2900050A1 (cg-RX-API-DMAC7.html)
EA (1) EA030414B1 (cg-RX-API-DMAC7.html)
HK (1) HK1214772A1 (cg-RX-API-DMAC7.html)
IL (1) IL240125A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015009908A (cg-RX-API-DMAC7.html)
PH (1) PH12015501705A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201505715RA (cg-RX-API-DMAC7.html)
WO (1) WO2014121210A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5048201B2 (ja) 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
CN102210852B (zh) 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ,インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
US10426796B2 (en) * 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US20210016273A1 (en) * 2019-07-19 2021-01-21 University Of Utah Research Foundation Rapid sperm separation based on sperm morphology and motility
US20230074374A1 (en) * 2020-02-16 2023-03-09 PUR Biologics, Inc Methods of manufacturing extracellular matrix using aspartyl alanyl diketopiperazine (da-dkp)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE765030A (fr) * 1970-04-02 1971-08-16 Snam Progetti Composes contenant un noyau de dicetopiperazine et leur procedede fabrication
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
JP2000005569A (ja) * 1998-06-24 2000-01-11 Asahi Chem Ind Co Ltd 直列多段濾過法
JP5048201B2 (ja) * 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
CN1791420A (zh) * 2003-05-15 2006-06-21 Dmi生物科学公司 T-细胞介导的疾病的治疗
CN102210852B (zh) * 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
JP4970260B2 (ja) * 2004-08-20 2012-07-04 プロメティック バイオサイエンシズ,リミテッド 親和性クロマトグラフィーによるタンパク質の逐次的単離および精製スキーム
AU2010311332B2 (en) * 2009-10-30 2015-04-23 Albumedix Ltd. Albumin variants
WO2012174472A1 (en) * 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
PH12014500685B1 (en) * 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP2014530063A (ja) * 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ,インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
HK1198812A1 (en) * 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis

Also Published As

Publication number Publication date
EP2950811A1 (en) 2015-12-09
US20150366932A1 (en) 2015-12-24
JP6387019B2 (ja) 2018-09-05
AU2014212095A1 (en) 2015-09-10
EP2950811A4 (en) 2016-06-08
MX2015009908A (es) 2015-09-24
IL240125A0 (en) 2015-09-24
CA2900050A1 (en) 2014-08-07
JP2016511238A (ja) 2016-04-14
SG11201505715RA (en) 2015-08-28
WO2014121210A1 (en) 2014-08-07
AU2014212095B2 (en) 2018-07-26
EA201500783A1 (ru) 2016-05-31
BR112015017958A2 (pt) 2017-07-11
KR20150114984A (ko) 2015-10-13
SG10201706213RA (en) 2017-09-28
CN105188737A (zh) 2015-12-23
PH12015501705A1 (en) 2015-10-12
EA030414B1 (ru) 2018-08-31

Similar Documents

Publication Publication Date Title
PH12015501705A1 (en) Methods for producing diketopiperazines and compositions containing diketopiperazines
PH12019500694A1 (en) Factor viii compositions and methods of making and using the same
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
WO2013184938A3 (en) Fusion polypeptides comprising mucin-domain polypeptide linkers
EP2470670A4 (en) FRAGRAPHIC VII COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
NZ705370A (en) Fcγriib-specific fc region variant
EA201190326A8 (ru) Полипептиды гормона роста и способы их получения и применения
SG10201906859PA (en) Novel proteins specific for angiogenesis
MX2009002816A (es) Proteinas de fusion de albumina.
MX362028B (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
MX360211B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX363136B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
WO2005063820A3 (en) Il-7 fusion proteins
NZ628126A (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
TNSN08064A1 (en) Albumin fusion proteins
WO2007092772A3 (en) Protein formulations
EA201270225A1 (ru) СОЕДИНЕНИЯ ДЛЯ УМЕНЬШЕНИЯ ПРОДУКЦИИ β-АМИЛОИДА
HK1206765A1 (en) Nutritive fragments, proteins and methods
WO2013055888A3 (en) Recombinant human naglu protein and uses thereof
UA107180C2 (uk) Туберкульозний білок rv1753c, композиція, що його містить, та застосування
IN2014DN09815A (cg-RX-API-DMAC7.html)
WO2015086686A3 (en) Protease resistant peptides
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
MX2021005346A (es) Constructos de suministro para transcitosis y metodos relacionados.
MX2023003348A (es) Compuestos y composiciones como moduladores de señalización tlr.